| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 168,992 | 186,207 | 173,848 | 206,357 | | Cost of Revenue | 72,321 | 83,695 | 82,553 | 97,731 | | | Gross Profit | 96,671 | 102,512 | 91,295 | 108,626 | | | Operating Expenses | | Research Development | 20,618 | 19,708 | 18,209 | 22,542 | | Selling General and Administrative | 55,126 | 59,064 | 52,745 | 65,151 | | Non Recurring | 75 | 8,934 | 3,534 | 7,717 | | Others | 1,880 | 2,017 | 1,890 | 2,358 | | | | Total Operating Expenses | 77,699 | 89,723 | 76,378 | 97,768 | | | | Operating Income or Loss | 18,972 | 12,789 | 14,917 | 10,858 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 220 | 387 | 1,119 | 2,188 | | Earnings Before Interest And Taxes | 19,192 | 13,176 | 16,036 | 13,046 | | Interest Expense | 4,450 | 1,951 | 1,931 | 2,019 | | Income Before Tax | 14,742 | 11,225 | 14,105 | 11,027 | | Income Tax Expense | 8,765 | 1,380 | 6,718 | 6,819 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,977 | 9,845 | 7,387 | 4,208 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,977 | 9,845 | 7,387 | 4,208 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,977 | $9,845 | $7,387 | $4,208 |
|
1.00% Nasdaq 
Income Statement
